WHY Drug Repurposing is NOT Enough
📢 CALL for NEUROSCIENTISTS 📢 🔺 New drug development for #Alzheimer’s disease has a 99% failure rate… This MUST CHANGE If we are serious about tackling the impending GLOBAL BRAIN HEALTH CRISIS. ❌ Let’s face it, without a proactive approach to a brain healthy culture, the $2.5 trillion price tag per year in lost productivity will continue to increasingly balloon. This is increasingly taxing our health systems, our families, and compromising our ability to maintain sustainability economically and socially. 👉🏽 While there are multiple drug repurposing studies being conducted, many target the population as a whole. Inevitably , this results in some of the same limitations that traditional non-stratified drug development faces. 🔺 A part of this limitation revolves around the current research on Alzheimer’s not being representative of the world population. The challenge has been that for the most part, most of the genetic, economic data of Alzheimer’s